A detailed history of Israel Englander (Millennium Management LLC) transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 5,099,529 shares of CDMO stock, worth $52.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,099,529
Previous 4,404,017 15.79%
Holding current value
$52.7 Million
Previous $29.5 Million 23.4%
% of portfolio
0.02%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $4.41 Million - $6.45 Million
695,512 Added 15.79%
5,099,529 $36.4 Million
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $960,278 - $1.44 Million
163,870 Added 3.86%
4,404,017 $29.5 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $19.7 Million - $40.5 Million
4,240,147 New
4,240,147 $27.6 Million
Q1 2023

May 15, 2023

BUY
$13.48 - $18.79 $594,265 - $828,357
44,085 Added 265.99%
60,659 $1.14 Million
Q4 2022

Feb 14, 2023

SELL
$12.61 - $18.74 $139,857 - $207,845
-11,091 Reduced 40.09%
16,574 $228,000
Q3 2022

Nov 14, 2022

SELL
$15.33 - $20.36 $959,964 - $1.27 Million
-62,620 Reduced 69.36%
27,665 $529,000
Q2 2022

Aug 15, 2022

BUY
$11.63 - $21.55 $572,917 - $1.06 Million
49,262 Added 120.08%
90,285 $1.38 Million
Q1 2022

May 16, 2022

SELL
$16.63 - $27.73 $7.47 Million - $12.5 Million
-449,436 Reduced 91.64%
41,023 $836,000
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $4.59 Million - $6.83 Million
241,037 Added 96.64%
490,459 $10.6 Million
Q2 2021

Aug 16, 2021

BUY
$18.93 - $25.65 $957,536 - $1.3 Million
50,583 Added 25.44%
249,422 $6.4 Million
Q1 2021

May 17, 2021

SELL
$11.86 - $21.77 $5.37 Million - $9.86 Million
-452,872 Reduced 69.49%
198,839 $3.63 Million
Q4 2020

Feb 16, 2021

SELL
$7.25 - $11.76 $14.7 Million - $23.8 Million
-2,027,273 Reduced 75.67%
651,711 $7.52 Million
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $4.14 Million - $5.45 Million
633,918 Added 31.0%
2,678,984 $20.4 Million
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $5.53 Million - $9.12 Million
1,344,897 Added 192.08%
2,045,066 $13.4 Million
Q1 2020

May 14, 2020

SELL
$3.15 - $7.39 $1.04 Million - $2.44 Million
-330,454 Reduced 32.06%
700,169 $3.58 Million
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $1.02 Million - $1.66 Million
203,339 Added 24.58%
1,030,623 $7.91 Million
Q3 2019

Nov 14, 2019

BUY
$5.07 - $7.08 $4.08 Million - $5.7 Million
804,833 Added 3584.84%
827,284 $4.38 Million
Q2 2019

Aug 14, 2019

SELL
$3.43 - $5.6 $38,062 - $62,143
-11,097 Reduced 33.08%
22,451 $126,000
Q1 2019

May 14, 2019

SELL
$3.56 - $4.82 $19,758 - $26,751
-5,550 Reduced 14.2%
33,548 $143,000
Q4 2018

Feb 14, 2019

SELL
$4.04 - $6.75 $483,006 - $807,003
-119,556 Reduced 75.36%
39,098 $160,000
Q3 2018

Nov 14, 2018

BUY
$4.28 - $7.32 $505,176 - $863,994
118,032 Added 290.56%
158,654 $1.09 Million
Q2 2018

Aug 14, 2018

SELL
$3.1 - $3.93 $428,584 - $543,334
-138,253 Reduced 77.29%
40,622 $159,000
Q1 2018

May 15, 2018

BUY
$2.32 - $4.22 $414,990 - $754,852
178,875 New
178,875 $522,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $643M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.